Search

James William Rogers

Examiner (ID: 13796)

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
1194
Issued Applications
502
Pending Applications
144
Abandoned Applications
586

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17702604 [patent_doc_number] => 20220202610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => CONTACT LENS WITH SUSTAINED RELEASE PROPERTY [patent_app_type] => utility [patent_app_number] => 17/139360 [patent_app_country] => US [patent_app_date] => 2020-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5143 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139360 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/139360
CONTACT LENS WITH SUSTAINED RELEASE PROPERTY Dec 30, 2020 Abandoned
Array ( [id] => 18280235 [patent_doc_number] => 20230095707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/790079 [patent_app_country] => US [patent_app_date] => 2020-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19934 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790079 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/790079
MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY Dec 29, 2020 Pending
Array ( [id] => 16778190 [patent_doc_number] => 20210115268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/137564 [patent_app_country] => US [patent_app_date] => 2020-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8173 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137564 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/137564
FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF Dec 29, 2020 Abandoned
Array ( [id] => 16762354 [patent_doc_number] => 20210107935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => NOVEL, HEAVY VITAMIN B12 DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/128511 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128511 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/128511
Heavy vitamin B12 derivatives Dec 20, 2020 Issued
Array ( [id] => 18282966 [patent_doc_number] => 20230098438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING [patent_app_type] => utility [patent_app_number] => 17/790698 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790698 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/790698
OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING Dec 20, 2020 Pending
Array ( [id] => 18159274 [patent_doc_number] => 20230025866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/787545 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5324 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787545 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787545
NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES Dec 17, 2020 Pending
Array ( [id] => 16719995 [patent_doc_number] => 20210087142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS [patent_app_type] => utility [patent_app_number] => 17/116501 [patent_app_country] => US [patent_app_date] => 2020-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9123 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116501 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/116501
Formulation for soft anticholinergic analogs Dec 8, 2020 Issued
Array ( [id] => 16717751 [patent_doc_number] => 20210084898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => METHOD OF USING HYDROPHILIZED BACTERICIDAL POLYMERS [patent_app_type] => utility [patent_app_number] => 17/115709 [patent_app_country] => US [patent_app_date] => 2020-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17115709 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/115709
Method of using hydrophilized bactericidal polymers Dec 7, 2020 Issued
Array ( [id] => 16760958 [patent_doc_number] => 20210106539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => DELIVERY OF DRUG NANOPARTICLES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/112674 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26626 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112674
Delivery of drug nanoparticles and methods of use thereof Dec 3, 2020 Issued
Array ( [id] => 16718679 [patent_doc_number] => 20210085826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/111890 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10148 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111890 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/111890
Crosslinkable polymer compositions Dec 3, 2020 Issued
Array ( [id] => 18280579 [patent_doc_number] => 20230096051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY [patent_app_type] => utility [patent_app_number] => 17/784215 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13229 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784215 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/784215
CGRP ANTIGONISTS USEFUL AS TRACER COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY Dec 3, 2020 Abandoned
Array ( [id] => 18485020 [patent_doc_number] => 20230212340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY [patent_app_type] => utility [patent_app_number] => 17/781731 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781731
CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY Dec 3, 2020 Pending
Array ( [id] => 16718678 [patent_doc_number] => 20210085825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => CROSSLINKABLE POLYMER COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/111878 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10147 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111878 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/111878
Crosslinkable polymer compositions Dec 3, 2020 Issued
Array ( [id] => 18485020 [patent_doc_number] => 20230212340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY [patent_app_type] => utility [patent_app_number] => 17/781731 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781731 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781731
CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY Dec 3, 2020 Pending
Array ( [id] => 18273739 [patent_doc_number] => 11612660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-28 [patent_title] => Dendrimer compositions and methods for drug delivery to the eye [patent_app_type] => utility [patent_app_number] => 17/112255 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 20646 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112255
Dendrimer compositions and methods for drug delivery to the eye Dec 3, 2020 Issued
Array ( [id] => 16883845 [patent_doc_number] => 20210170040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/112541 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112541 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112541
DENDRIMER COMPOSITIONS AND METHODS FOR DRUG DELIVERY Dec 3, 2020 Abandoned
Array ( [id] => 16876799 [patent_doc_number] => 11026919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-08 [patent_title] => Formulation for soft anticholinergic analogs [patent_app_type] => utility [patent_app_number] => 17/107942 [patent_app_country] => US [patent_app_date] => 2020-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9870 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17107942 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/107942
Formulation for soft anticholinergic analogs Nov 29, 2020 Issued
Array ( [id] => 16710312 [patent_doc_number] => 20210077459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS [patent_app_type] => utility [patent_app_number] => 17/107908 [patent_app_country] => US [patent_app_date] => 2020-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9790 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17107908 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/107908
Formulation for soft anticholinergic analogs Nov 29, 2020 Issued
Array ( [id] => 18363247 [patent_doc_number] => 20230144838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS [patent_app_type] => utility [patent_app_number] => 17/778242 [patent_app_country] => US [patent_app_date] => 2020-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778242 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778242
THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS Nov 16, 2020 Pending
Array ( [id] => 18363247 [patent_doc_number] => 20230144838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS [patent_app_type] => utility [patent_app_number] => 17/778242 [patent_app_country] => US [patent_app_date] => 2020-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17778242 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/778242
THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS Nov 16, 2020 Pending
Menu